🔴 Vivani Medical is trading 6.25% down today on profit-taking after its recent rally

Vivani Medical is trading at $1.50 (-6.25%) as investors take profits following a significant rally triggered by recent collaboration news.

• Shares are giving back a portion of the prior session’s 18.52% jump, which followed the July 7 announcement that Novo Nordisk agreed to evaluate Vivani’s NPM-139 semaglutide implant.
• No new company-specific catalysts or negative developments have been reported to explain the July 9 decline.
• The downward move contrasts with broader U.S. markets, which are trading higher, suggesting a technical pullback rather than a change in fundamental sentiment.